Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Long-Term Investments (2020 - 2023)

Historic Long-Term Investments for Gyre Therapeutics (GYRE) over the last 9 years, with Q4 2023 value amounting to $49.7 million.

  • Gyre Therapeutics' Long-Term Investments rose 2233.95% to $49.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $49.7 million, marking a year-over-year increase of 2233.95%. This contributed to the annual value of $49.7 million for FY2023, which is 2233.95% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Long-Term Investments of $49.7 million as of Q4 2023, which was up 2233.95% from $40.6 million recorded in Q4 2022.
  • Gyre Therapeutics' 5-year Long-Term Investments high stood at $49.7 million for Q4 2023, and its period low was $1.2 million during Q3 2020.
  • Over the past 3 years, Gyre Therapeutics' median Long-Term Investments value was $21.6 million (recorded in 2020), while the average stood at $23.5 million.
  • Examining YoY changes over the last 5 years, Gyre Therapeutics' Long-Term Investments showed a top increase of 2233.95% in 2023 and a maximum decrease of 2233.95% in 2023.
  • Gyre Therapeutics' Long-Term Investments (Quarter) stood at $2.5 million in 2020, then skyrocketed by 1497.8% to $40.6 million in 2022, then grew by 22.34% to $49.7 million in 2023.
  • Its Long-Term Investments was $49.7 million in Q4 2023, compared to $40.6 million in Q4 2022 and $2.5 million in Q4 2020.